Tom Shehab joined Arboretum Ventures in 2014 as a Principal and became a Managing Partner in 2017. Prior to joining the Arboretum team, Tom served as a member of Arboretum’s Technical Advisory Board. Tom draws upon his extensive clinical, healthcare administration and operational experience to invest in medical device and IT enabled healthcare companies that focus on improving patient outcomes while decreasing healthcare costs. He also provides strategic support to Arboretum portfolio companies and served as Chief Medical Officer for ArborMetrix where he led strategic positioning and clinically focused efforts. Tom currently serves as Board Director for Avation Medical, Fifth Eye, Health Scholars and SonarMD and is a Board Observer for PEAR Therapeutics and has previously served as a board member for Aira Tech, ArborMetrix, Lucina Heath and nVision Medical.

Prior to joining Arboretum, Tom spent 12 years as a physician executive and practicing physician specializing in gastroenterology. He was involved in a number of entrepreneurial healthcare-related ventures and held multiple senior leadership roles. Most recently, Tom served as Chief of Staff for more than 1,000 physicians at St. Joseph Mercy Hospital in Ann Arbor and as the Chair of Medicine for Integrated Health Associates (IHA), a multi-specialty group consisting of 300+ providers. Both St. Joseph Mercy Hospital and IHA are part of Trinity Health.

Tom is engaged as board member for several healthcare and innovation focused organizations including the Cleveland Clinic Medical Device Advisory Council, the Center for Machine Learning and Health at Carnegie Mellon University, and was the immediate past Chair of the Michigan Venture Capital Association.

Tom earned an M.D. from Wayne State University, performed his residency, chief residency, and fellowship training at the University of Michigan Medical Center, and earned his Master’s in Medical Management from the Heinz School of Management at Carnegie Mellon University.

BioPathways is a monthly event series, featuring prominent bioentrepreneurs, biotech executives and biotech investors in a fireside chat.

Mining Midwest Biotech Treasures: Part Two